PDL BioPharma, Inc. Company Profile Complimentary D&B Business Overview on over 38 million companies with Free Registration!

PDL BioPharma, Inc.
34801 Campus Drive
Fremont, CA 94555
United States
Tel: 1/510-574-1400
URL: http://www.pdl.com
Formerly known as:
Protein Design Labs, Inc.
Primary Symbols & Exchanges:
PDLI - NASDAQ
Primary Industry:
Biotechnology
SIC Industry Code:
NAICS Industry Code:
Thomson Financial Business Description:
The Group's principal activity is the development of humanized monoclonal antibodies for the treatment of diseases. The key areas of disease focus include oncology and inflammatory and autoimmune diseases. It has several humanized antibodies in clinical development for inflammatory bowel disease, psoriasis and asthma. The Group has licensed certain rights to first humanized antibody product, Zenpax to Hoffmann-La Roche Inc and its affiliates, which markets it for the prevention of kidney transplant rejection. The Groups Registered Trademarks are Protein Design Labs, Nuvion and Humanizing Science. The Group operates mainly in the domestic market.
Alacra Alerts: PDL BioPharma, Inc. RSS Feed  Subscribe with My Yahoo!
Receive alerts on the latest reports on PDL BioPharma, Inc.

Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.

Premium Content Results:







Search for more premium content on PDL BioPharma, Inc.
  about us contact us public company index private company index pcan your privacy rights terms & conditions